Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Aduro Biotech, Inc. (NASDAQ: ADRO).

Full DD Report for ADRO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ADRO)

Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced the publication of a peer reviewed paper in Leukemia authored by scientists from the Dana Farber Cancer Institute and Aduro as part of their ongoing collaboration to study the role of A...
Source: GlobeNewswire
Date: September, 04 2018 16:06
Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that preclinical data for its first-in-class anti-APRIL antibody BION-1301 was presented at the 5 th European Congress of Immunology in Amsterdam, The Netherlands. Data from the preclinic...
Source: GlobeNewswire
Date: September, 04 2018 16:01
Week 36 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 36: Market conditions have generated a strong increase in positive breakout momentum and a decline negative momentum this week. The positive momentum gauge continues higher to 65 up from a value of 51 at the end of last week. The yellow positive mome...
Source: SeekingAlpha
Date: September, 01 2018 13:03
Aduro Biotech to Present at the 20th Annual H.C. Wainwright Global Investment Conference
BERKELEY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 20th Annual H.C. Wainwright Global Investment Conference in New York, NY on Wednesday,...
Source: GlobeNewswire
Date: August, 29 2018 16:01
Recent Analysis Shows Clearwater Paper, Aduro Biotech, Comtech Telecommunications, Ferroglobe, Badger Meter, and Donnelley Financial Solutions Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clearwater Paper Corporation (NYSE:CLW), Aduro Biotech, Inc. (NASDAQ:ADRO...
Source: GlobeNewswire
Date: August, 29 2018 07:50
Your Daily Pharma Scoop: Mallinckrodt Stumbles, AbbVie Phase 3 Positive, Sierra Makes An Acquisition
Stocks in News: MNK, ABBV FDA rejects Mallinckrodt's stannsoporfin marketing application; shares down 3% premarket Discussion: Mallinckrodt ( MNK ) received a CRL on its marketing application of stannsoporfin for the treatment of severe jaundice in neonatals at risk. The CRL w...
Source: SeekingAlpha
Date: August, 24 2018 09:23
Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies
BERKELEY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the United States Patent and Trademark Office has issued a new composition of matter patent related to altered APRIL-binding antibodies, further enhancing the company’s B-selec...
Source: GlobeNewswire
Date: August, 22 2018 16:01
Midday Gainers / Losers (08/17/2018)
Gainers: TIK +56% . ZOES +34% . IZEA +28% . CNET +19% . CRMT +18% . YRD +15% . GEMP +13% . PPDF +13% . JWN +12% . ADRO +11% . Losers: ZN -27% . USEG -17% . BOXL -16% . ATGE -15% . DXR -14% . ATAC -14% . AMRS -13% . JMU -14% . ELO...
Source: SeekingAlpha
Date: August, 17 2018 12:45
Aduro Biotech beats by $0.01, misses on revenue
Aduro Biotech (NASDAQ: ADRO ): Q2 EPS of -$0.31 beats by $0.01 . More news on: Aduro Biotech, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 01 2018 16:49
Aduro Biotech Reports Second Quarter 2018 Financial Results
BERKELEY, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the second quarter ended June 30, 2018. Net loss for the second quarter of 2018 was $24.4 million, or $0.31 per share, and for the six months ended June 30, 2018 net l...
Source: GlobeNewswire
Date: August, 01 2018 16:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-087.807.057.8757.00257,572
2018-05-178.158.108.2758.05551,846
2017-02-0211.8511.7511.8511.575295,490
2017-02-0111.8011.9012.0011.60349,086
2017-01-3111.0511.8511.92510.75211,478

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1772,425215,19833.6551Cover
2018-12-1462,62688,95470.4027Short
2018-12-1334,29957,93559.2026Short
2018-12-1243,262124,41034.7737Cover
2018-12-11246,0081,190,99120.6557Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ADRO.


About Aduro Biotech, Inc. (NASDAQ: ADRO)

Logo for Aduro Biotech, Inc. (NASDAQ: ADRO)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $661,333,277 - 05/14/2018
  • Issue and Outstanding: 78,730,152 - 04/27/2018

 


Recent Filings from (NASDAQ: ADRO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 20 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 12 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 12 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 01 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: February, 13 2018

 

 


Daily Technical Chart for (NASDAQ: ADRO)

Daily Technical Chart for (NASDAQ: ADRO)


Stay tuned for daily updates and more on (NASDAQ: ADRO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ADRO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ADRO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ADRO and does not buy, sell, or trade any shares of ADRO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/